Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
BioNTech (BNTX-Q) has recently received positive feedback from stock analysts, highlighting its strong performance in the market. The stock has been designated as a 'Top Pick' as of December 21, 2023, with a notable increase of 9.3%. Analysts, including Michael O'Reilly from Stockchase Research, emphasize the importance of risk management in investment strategies, suggesting that investors adjust their stop-loss order from $78 to $95 to secure profits while allowing for potential further gains. Overall, the sentiment around BioNTech appears optimistic, reflecting the company's ongoing successes and growth potential in the biopharmaceutical sector. As always, investors should keep abreast of market trends and company developments to make informed decisions.
Provides the key insight into mRNA that underlies the Covid vaccine. The mRNA technology can be developed into therapies that are targeted and safe. They are working on a flu vaccine as well as a cancer vaccine. Their pipeline is vast and the coronavirus vaccine is giving a huge cash hoard to pay for R&D. (Analysts’ price target is $185.00)
BioNTech is a American stock, trading under the symbol BNTX-Q on the NASDAQ (BNTX). It is usually referred to as NASDAQ:BNTX or BNTX-Q
In the last year, 3 stock analysts published opinions about BNTX-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for BioNTech.
BioNTech was recommended as a Top Pick by on . Read the latest stock experts ratings for BioNTech.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered BioNTech In the last year. It is a trending stock that is worth watching.
On 2025-05-01, BioNTech (BNTX-Q) stock closed at a price of $102.43.
Our PAST TOP PICK with BNTX is progressing well. To remain disciplined, we recommend trailing up the stop (from $78) to $95 at this time.